| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| STVNStevanato Group S.p.A. | 1.04B | 21.00 | 48.84 | 1.72% | 12.01% | 9.78% | 0.31 | |
| WSTWest Pharmaceutical Services, Inc. | 20.1B | 279.41 | 41.77 | -1.98% | 16.3% | 16.11% | 1.38% | 0.11 |
| ATRAptarGroup, Inc. | 8.21B | 125.11 | 22.62 | 2.74% | 11.45% | 14.91% | 4.25% | 0.43 |
| MHUAMeihua International Medical Technologies Co., Ltd. | 181.69M | 3.25 | 0.08 | -0.19% | 10.09% | 11.25% | 7.98% | 0.05 |
| Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|
| Sales/Revenue | 536.54M | 662.04M | 843.92M | 983.68M | 1.09B | 1.1B |
| Revenue Growth % | - | 0.23% | 0.27% | 0.17% | 0.1% | 0.02% |
| Cost of Goods Sold | 398.52M | 467.86M | 578.51M | 663.88M | 745.46M | 801.72M |
| COGS % of Revenue | 0.74% | 0.71% | 0.69% | 0.67% | 0.69% | 0.73% |
| Gross Profit | 138.02M | 194.18M | 265.4M | 319.8M | 339.89M | 302.32M |
| Gross Margin % | 0.26% | 0.29% | 0.31% | 0.33% | 0.31% | 0.27% |
| Gross Profit Growth % | - | 0.41% | 0.37% | 0.2% | 0.06% | -0.11% |
| Operating Expenses | 75.8M | 91.07M | 103.18M | 127.37M | 139.17M | 141.18M |
| OpEx % of Revenue | 0.14% | 0.14% | 0.12% | 0.13% | 0.13% | 0.13% |
| Selling, General & Admin | 76.71M | 78.91M | 82.95M | 111.83M | 113.92M | 118.6M |
| SG&A % of Revenue | 0.14% | 0.12% | 0.1% | 0.11% | 0.1% | 0.11% |
| Research & Development | 7.83M | 17.39M | 29.62M | 34.39M | 35.67M | 31.67M |
| R&D % of Revenue | 0.01% | 0.03% | 0.04% | 0.03% | 0.03% | 0.03% |
| Other Operating Expenses | -8.74M | -5.23M | -9.39M | -18.85M | -10.42M | -9.09M |
| Operating Income | 62.22M | 103.11M | 162.22M | 192.43M | 200.72M | 161.14M |
| Operating Margin % | 0.12% | 0.16% | 0.19% | 0.2% | 0.18% | 0.15% |
| Operating Income Growth % | - | 0.66% | 0.57% | 0.19% | 0.04% | -0.2% |
| EBITDA | 108.44M | 157.21M | 218.61M | 257.25M | 279.2M | 241.79M |
| EBITDA Margin % | 0.2% | 0.24% | 0.26% | 0.26% | 0.26% | 0.22% |
| EBITDA Growth % | - | 0.45% | 0.39% | 0.18% | 0.09% | -0.13% |
| D&A (Non-Cash Add-back) | 46.22M | 54.1M | 56.38M | 64.82M | 78.48M | 80.65M |
| EBIT | 60.32M | 102.27M | 170.54M | 191.58M | 193.87M | 167.15M |
| Net Interest Income | -5.34M | -6.37M | -4.32M | -3.29M | -3.52M | -5.14M |
| Interest Income | 175K | 424.07K | 548K | 648K | 792K | 1.72M |
| Interest Expense | 5.61M | 6.79M | 4.87M | 3.94M | 4.32M | 6.86M |
| Other Income/Expense | -7.51M | -6.83M | 3.45M | -4.79M | -11.17M | -854K |
| Pretax Income | 54.71M | 96.28M | 165.67M | 187.64M | 189.55M | 160.29M |
| Pretax Margin % | 0.1% | 0.15% | 0.2% | 0.19% | 0.17% | 0.15% |
| Income Tax | 16.01M | 17.68M | 31.4M | 44.63M | 43.86M | 42.52M |
| Effective Tax Rate % | 0.72% | 0.82% | 0.81% | 0.76% | 0.77% | 0.73% |
| Net Income | 39.2M | 78.51M | 134.32M | 142.85M | 145.63M | 117.78M |
| Net Margin % | 0.07% | 0.12% | 0.16% | 0.15% | 0.13% | 0.11% |
| Net Income Growth % | - | 1% | 0.71% | 0.06% | 0.02% | -0.19% |
| Net Income (Continuing) | 38.71M | 78.6M | 134.27M | 143.02M | 145.69M | 117.77M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | -50K | -355K | -415K | -220K | 115K | 46K |
| EPS (Diluted) | 0.15 | 0.28 | 0.53 | 0.53 | 0.55 | 0.43 |
| EPS Growth % | - | 0.87% | 0.89% | 0% | 0.04% | -0.22% |
| EPS (Basic) | 0.15 | 0.28 | 0.53 | 0.53 | 0.55 | 0.43 |
| Diluted Shares Outstanding | 264.7M | 264.7M | 264.7M | 264.7M | 264.98M | 272.88M |
| Basic Shares Outstanding | 264.7M | 264.7M | 264.7M | 264.7M | 264.95M | 272.87M |
| Dividend Payout Ratio | 0.16% | 0.11% | 0.08% | 0.09% | 0.1% | 0.12% |
| Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|
| Total Current Assets | 449.58M | 492.77M | 865.97M | 845.77M | 861.89M | 880.12M |
| Cash & Short-Term Investments | 126.27M | 157.12M | 438.21M | 256.65M | 70.35M | 98.27M |
| Cash Only | 85.39M | 115.6M | 411.04M | 228.74M | 69.6M | 98.27M |
| Short-Term Investments | 40.88M | 41.52M | 27.17M | 27.91M | 749K | 0 |
| Accounts Receivable | 160.58M | 167.25M | 278.42M | 369.48M | 522.48M | 529.87M |
| Days Sales Outstanding | 109.24 | 92.21 | 120.42 | 137.1 | 175.71 | 175.18 |
| Inventory | 131.88M | 139.37M | 148.92M | 213.25M | 255.32M | 245.22M |
| Days Inventory Outstanding | 120.79 | 108.73 | 93.96 | 117.25 | 125.01 | 111.64 |
| Other Current Assets | 30.55M | 28.62M | 49K | 5.69M | 3.63M | 933K |
| Total Non-Current Assets | 432.6M | 475.2M | 552.87M | 813.92M | 1.21B | 1.45B |
| Property, Plant & Equipment | 306.93M | 339.04M | 415.41M | 660.69M | 1.05B | 1.26B |
| Fixed Asset Turnover | 1.75x | 1.95x | 2.03x | 1.49x | 1.04x | 0.87x |
| Goodwill | 47.24M | 47.24M | 47.24M | 47.24M | 49.98M | 49.98M |
| Intangible Assets | 34.82M | 33.9M | 31.93M | 32.16M | 30.98M | 33.59M |
| Long-Term Investments | 4.61M | 3.51M | 1.97M | 1.83M | 5.15M | 5.64M |
| Other Non-Current Assets | 5.9M | 5.96M | 447K | 2.79M | 577K | 0 |
| Total Assets | 882.18M | 967.98M | 1.42B | 1.66B | 2.07B | 2.33B |
| Asset Turnover | 0.61x | 0.68x | 0.59x | 0.59x | 0.52x | 0.47x |
| Asset Growth % | - | 0.1% | 0.47% | 0.17% | 0.25% | 0.12% |
| Total Current Liabilities | 262.94M | 316.18M | 338.62M | 462.5M | 574.39M | 477.47M |
| Accounts Payable | 95.05M | 118.74M | 164.79M | 239.18M | 277.81M | 231.02M |
| Days Payables Outstanding | 87.06 | 92.63 | 103.97 | 131.5 | 136.03 | 105.18 |
| Short-Term Debt | 65.35M | 63.45M | 37.17M | 64.63M | 135.6M | 106.84M |
| Deferred Revenue (Current) | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K |
| Other Current Liabilities | 10.83M | 17.49M | 5.33M | -3.73M | 11.15M | 15.45M |
| Current Ratio | 1.71x | 1.56x | 2.56x | 1.83x | 1.50x | 1.84x |
| Quick Ratio | 1.21x | 1.12x | 2.12x | 1.37x | 1.06x | 1.33x |
| Cash Conversion Cycle | 142.97 | 108.31 | 110.41 | 122.84 | 164.69 | 181.64 |
| Total Non-Current Liabilities | 353.8M | 341.66M | 238.56M | 201.29M | 364.54M | 446.96M |
| Long-Term Debt | 290.88M | 273.94M | 183.99M | 133.75M | 242.05M | 305.23M |
| Capital Lease Obligations | 21.26M | 20.19M | 17.57M | 14.66M | 13.1M | 11.81M |
| Deferred Tax Liabilities | 10.43M | 11.62M | 19.11M | 20.95M | 9.62M | 12.56M |
| Other Non-Current Liabilities | 37.93M | 35.92M | 17.89M | 31.93M | 60.35M | 73.32M |
| Total Liabilities | 616.74M | 657.84M | 577.18M | 663.79M | 938.93M | 924.43M |
| Total Debt | 375.67M | 363.01M | 244.29M | 218.37M | 396.59M | 428.97M |
| Net Debt | 290.28M | 247.41M | -166.75M | -10.37M | 326.99M | 330.7M |
| Debt / Equity | 1.42x | 1.17x | 0.29x | 0.22x | 0.35x | 0.31x |
| Debt / EBITDA | 3.46x | 2.31x | 1.12x | 0.85x | 1.42x | 1.77x |
| Net Debt / EBITDA | 2.68x | 1.57x | -0.76x | -0.04x | 1.17x | 1.37x |
| Interest Coverage | 11.10x | 15.18x | 33.30x | 48.89x | 46.52x | 23.48x |
| Total Equity | 265.44M | 310.14M | 841.66M | 995.91M | 1.13B | 1.4B |
| Equity Growth % | - | 0.17% | 1.71% | 0.18% | 0.14% | 0.24% |
| Book Value per Share | 1.00 | 1.17 | 3.18 | 3.76 | 4.27 | 5.15 |
| Total Shareholders' Equity | 265.49M | 310.5M | 842.07M | 996.13M | 1.13B | 1.4B |
| Common Stock | 20M | 20M | 21.7M | 21.7M | 21.7M | 22.23M |
| Retained Earnings | 0 | 0 | 0 | 623.35M | 757.86M | 863.44M |
| Treasury Stock | 0 | 0 | 0 | -27.74M | -27.23M | -27.15M |
| Accumulated OCI | 206.29M | 211.98M | 686.05M | -10.49M | -9.11M | -13.75M |
| Minority Interest | -50K | -355K | -415K | -220K | 115K | 46K |
| Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|
| Cash from Operations | 42.57M | 155.66M | 133.34M | 103.31M | 105.21M | 155.78M |
| Operating CF Margin % | 0.08% | 0.24% | 0.16% | 0.11% | 0.1% | 0.14% |
| Operating CF Growth % | - | 2.66% | -0.14% | -0.23% | 0.02% | 0.48% |
| Net Income | 54.71M | 96.28M | 165.67M | 187.64M | 189.55M | 160.29M |
| Depreciation & Amortization | 46.22M | 54.1M | 56.38M | 64.82M | 78.48M | 80.65M |
| Stock-Based Compensation | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -33.39M | -27.9M | -47.09M | -31.41M | -60.34M | -67.76M |
| Working Capital Changes | -24.97M | 33.18M | -41.63M | -117.74M | -102.48M | -17.41M |
| Change in Receivables | 5.87M | -3.63M | -54.77M | -46.42M | -93.86M | -3.83M |
| Change in Inventory | -42.67M | -15.6M | -31.2M | -107.37M | -113.59M | 12.31M |
| Change in Payables | 11.84M | 52.41M | 44.34M | 36.05M | 104.97M | -25.89M |
| Cash from Investing | -74.34M | -96.09M | -96.43M | -242.95M | -421.22M | -310.21M |
| Capital Expenditures | -68.09M | -89.56M | -107.69M | -235.03M | -433.23M | -302.6M |
| CapEx % of Revenue | 0.13% | 0.14% | 0.13% | 0.24% | 0.4% | 0.27% |
| Acquisitions | - | - | - | - | - | - |
| Investments | - | - | - | - | - | - |
| Other Investing | -5.62M | -6.42M | -4.32M | -7.95M | 15.6M | -7.44M |
| Cash from Financing | 42.17M | -26.52M | 254.85M | -44.54M | 158.03M | 183.22M |
| Debt Issued (Net) | - | - | - | - | - | - |
| Equity Issued (Net) | - | - | - | - | - | - |
| Dividends Paid | -6.17M | -8.9M | -11.2M | -13.5M | -14.29M | -14.46M |
| Share Repurchases | - | - | - | - | - | - |
| Other Financing | 0 | -539K | 6.13M | 0 | -250K | 0 |
| Net Change in Cash | - | - | - | - | - | - |
| Free Cash Flow | -31.33M | 59.65M | 20.16M | -139.81M | -336.72M | -157.79M |
| FCF Margin % | -0.06% | 0.09% | 0.02% | -0.14% | -0.31% | -0.14% |
| FCF Growth % | - | 2.9% | -0.66% | -7.94% | -1.41% | 0.53% |
| FCF per Share | -0.12 | 0.23 | 0.08 | -0.53 | -1.27 | -0.58 |
| FCF Conversion (FCF/Net Income) | 1.09x | 1.98x | 0.99x | 0.72x | 0.72x | 1.32x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 |
| Metric | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Return on Equity (ROE) | 14.77% | 27.28% | 23.32% | 15.55% | 13.68% | 9.28% |
| Return on Invested Capital (ROIC) | 8.4% | 13.89% | 19.74% | 17.38% | 12.31% | 7.57% |
| Gross Margin | 25.72% | 29.33% | 31.45% | 32.51% | 31.32% | 27.38% |
| Net Margin | 7.31% | 11.86% | 15.92% | 14.52% | 13.42% | 10.67% |
| Debt / Equity | 1.42x | 1.17x | 0.29x | 0.22x | 0.35x | 0.31x |
| Interest Coverage | 11.10x | 15.18x | 33.30x | 48.89x | 46.52x | 23.48x |
| FCF Conversion | 1.09x | 1.98x | 0.99x | 0.72x | 0.72x | 1.32x |
| Revenue Growth | - | 23.39% | 27.47% | 16.56% | 10.34% | 1.72% |
| 2022 | 2023 | 2024 | |
|---|---|---|---|
| Europe Middle East And Africa | 599.71M | 634.05M | 667.83M |
| Europe Middle East And Africa Growth | - | 5.73% | 5.33% |
| North America | 250.84M | 317.54M | 308.95M |
| North America Growth | - | 26.59% | -2.70% |
| Asia Pacific | 100.26M | 102.9M | 96.23M |
| Asia Pacific Growth | - | 2.63% | -6.48% |
| South America | 32.87M | 30.87M | 31.02M |
| South America Growth | - | -6.08% | 0.49% |
Stevanato Group S.p.A. (STVN) has a price-to-earnings (P/E) ratio of 48.8x. This suggests investors expect higher future growth.
Stevanato Group S.p.A. (STVN) reported $1.17B in revenue for fiscal year 2024. This represents a 118% increase from $536.5M in 2019.
Stevanato Group S.p.A. (STVN) grew revenue by 1.7% over the past year. Growth has been modest.
Yes, Stevanato Group S.p.A. (STVN) is profitable, generating $140.6M in net income for fiscal year 2024 (10.7% net margin).
Yes, Stevanato Group S.p.A. (STVN) pays a dividend with a yield of 0.25%. This makes it attractive for income-focused investors.
Stevanato Group S.p.A. (STVN) has a return on equity (ROE) of 9.3%. This is below average, suggesting room for improvement.
Stevanato Group S.p.A. (STVN) had negative free cash flow of $33.7M in fiscal year 2024, likely due to heavy capital investments.